Patten Group, Inc. Abb Vie Inc. Transaction History

Patten Group, Inc.

$417 Million
Q2 2024

A detailed history of Patten Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Patten Group, Inc. holds 1,731 shares of ABBV stock, worth $338,202. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,731

Previous 1,731 -0.0%

Holding current value

$338,202

Previous $315,000 6.03%

% of portfolio

0.07%

Previous 0.08%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $13,105 - $14,932	-82 Reduced 4.52%	1,731 $315,000
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $34,400 - $38,742	-250 Reduced 12.12%	1,813 $280,000
Q3 2023 Oct 12, 2023	BUY	$133.59 - $154.65 $64,390 - $74,541	482 Added 30.49%	2,063 $307,000
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $1,325 - $1,649	-10 Reduced 0.63%	1,581 $213,000
Q1 2023 Apr 06, 2023	BUY	$144.61 - $166.54 $43,383 - $49,962	300 Added 23.24%	1,591 $253,000
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $178,558 - $214,138	1,291 New	1,291 $208,000
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $190,843 - $236,782	1,446 New	1,446 $234,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $198,095 - $233,148	-2,568 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $14,090 - $17,377	-181 Reduced 6.58%	2,568 $237,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $10,224 - $11,366	-115 Reduced 4.02%	2,749 $260,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $4,489 - $5,311	50 Added 1.78%	2,864 $265,000
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $736 - $985	8 Added 0.29%	2,814 $266,000
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $447 - $491	5 Added 0.18%	2,806 $271,000
Q3 2017 Dec 13, 2017	BUY	$69.85 - $89.22 $136,766 - $174,692	1,958 Added 232.27%	2,801 $249,000
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $138,093 - $176,387	-1,977 Reduced 70.11%	843 $249,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,820	2,820 $200,000

Others Institutions Holding ABBV

# of Institutions

3,697

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.

Account